N.Y.U. Langone Withdraws From Type 1 Diabetes Vaccine Trial in Adolescents
The B.C.G. vaccine, more than a century old, has shown some promise against diabetes. The university ’s move left parents and outside investigators concerned.
Source: NYT Health - Category: Consumer Health News Authors: Roni Caryn Rabin Tags: Diabetes Vaccination and Immunization Research Teenagers and Adolescence Clinical Trials Tuberculosis New York University Langone Health Source Type: news
More News: Clinical Trials | Diabetes | Diabetes Type 1 | Endocrinology | Health | New York University | Tuberculosis | Vaccines